@article{703688ec-36b4-4f99-aac3-830d83f79f63,
author = {Aleksandra  Zawada, Anna Korecka-Polak, Bartosz  Kobuszewski},
title = {Ceny leków – teoria i praktyka},
journal = {Zdrowie Publiczne i Zarządzanie},
volume = {2019},
number = {Tom 17, Numer 4},
year = {2019},
issn = {1731-7398},
pages = {194-202},keywords = {ceny leków; refundacja; poziom odpłatności; Komisja Ekonomiczna; Komisja Europejska; polityka lekowa państwa / drug pricing; reimbursement; payments; Economic Commission; European Commission; drug policy},
abstract = {Drug prices – theory and practice

	Prices of reimbursed drugs in Poland are regulated by law and closely monitored, which has been specified in reimbursement act. It contains, among others, rules regarding drug pricing, payments, limit groups and it also defines mechanisms of access to reimbursed medicines. In addition to aforementioned reimbursement act, the important role in drug policy in Poland plays the Economic Commission operating at the Ministry of Health and the European Commission. Current rules of drug financing from public funds in Poland are precisely detailed, and therefore may be incomprehensible to a large part of society. The aim of this publication is to present theoretical aspects of drug reimbursement and associated with

	this most common problems in practice.},
doi = {10.4467/20842627OZ.19.021.12183},
url = {https://ejournals.eu/czasopismo/zdrowie-publiczne-i-zarzadzanie/artykul/ceny-lekow-teoria-i-praktyka}
}